2-arachidonoylglycerol might be a novel therapeutic target in the treatment of cardiovascular disease

Affiliations

¹ Department of Nursing, Liaocheng Vocational & Technical College, Liaocheng 252000, PR China.
² Department of Cardiology, The Second People's Hospital of Liaocheng, Liaocheng 252000, PR China. Electronic address: xingfuyoujian@163.com.

Comment

Jingwen Liu et al. Int J Cardiol. 2021.

. 2021 Jun 1:332:162.

doi: 10.1016/j.ijcard.2021.03.075. Epub 2021 Mar 31.

¹ Department of Nursing, Liaocheng Vocational & Technical College, Liaocheng 252000, PR China.
² Department of Cardiology, The Second People's Hospital of Liaocheng, Liaocheng 252000, PR China. Electronic address: xingfuyoujian@163.com.

No abstract available

Comment on

The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair.
Jehle J, Eich L, Danisch M, Bagheri S, Avraamidou E, Pfeifer P, Tiyerili V, Bindila L, Lutz B, Nickenig G. Jehle J, et al. Int J Cardiol. 2021 Jan 15;323:243-250. doi: 10.1016/j.ijcard.2020.08.042. Epub 2020 Aug 15. Int J Cardiol. 2021. PMID: 32810540
The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair through cannabinoid 1 (CB1) receptor.
Hou LJ, Xie MY, Ye W, Zhao GJ. Hou LJ, et al. Int J Cardiol. 2021 Apr 1;328:176. doi: 10.1016/j.ijcard.2020.11.027. Epub 2020 Nov 17. Int J Cardiol. 2021. PMID: 33217478 No abstract available.